Trial Profile
INTACT: a randomised feasibility study of INtravenous iron versus usual care to Treat Anaemia in CriTical care survivors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2023
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms INTACT
- 01 Jun 2020 Status changed from active, no longer recruiting to completed.
- 22 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 23 Jul 2018 New trial record